With $120m, HI-Bio Aims To Rapidly Prove Approach To Immune-Mediated Diseases

Phase Ib/IIa Trials To Read Out Next Year

 
• By Mandy Jackson
  
Venture capital or financial support for startup and entrepreneur company
HI-Bio connected with new investor Jeito in its latest financing • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business